FDA Drug Recalls
17,898 recalls, newest first
Class II · Moderate risk Ongoing Jan 15, 2026
Reason Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing…
Class II · Moderate risk Ongoing Jan 14, 2026
Reason Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
Class II · Moderate risk Ongoing Jan 12, 2026
Reason Superpotent and Subpotent
Class II · Moderate risk Ongoing Jan 12, 2026
Reason Superpotent and Subpotent
Class II · Moderate risk Ongoing Jan 10, 2026
Reason Presence of Foreign Substance
Class II · Moderate risk Ongoing Jan 6, 2026
Reason cGMP deviations.
Class II · Moderate risk Ongoing Jan 2, 2026
Reason Presence of Particulate Matter.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Out of specification for dissolution.
Class II · Moderate risk Ongoing Dec 31, 2025
Reason Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Class II · Moderate risk Ongoing Dec 30, 2025
Reason Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
Class III · Low risk Ongoing Dec 30, 2025
Reason Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
Class II · Moderate risk Ongoing Dec 30, 2025
Reason Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
Class II · Moderate risk Ongoing Dec 27, 2025
Reason Incorrect Product Formulation: product did not contain insulin as listed in the label.
Class III · Low risk Ongoing Dec 26, 2025
Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
Class II · Moderate risk Ongoing Dec 26, 2025
Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Class II · Moderate risk Ongoing Dec 26, 2025
Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Class II · Moderate risk Ongoing Dec 26, 2025
Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Class II · Moderate risk Ongoing Dec 26, 2025
Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.